Ryan P. Werntz

602 total citations
23 papers, 389 citations indexed

About

Ryan P. Werntz is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Ryan P. Werntz has authored 23 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Urology. Recurrent topics in Ryan P. Werntz's work include Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (7 papers) and Testicular diseases and treatments (6 papers). Ryan P. Werntz is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (7 papers) and Testicular diseases and treatments (6 papers). Ryan P. Werntz collaborates with scholars based in United States. Ryan P. Werntz's co-authors include Gary D. Steinberg, Zachary L. Smith, Scott E. Eggener, Vignesh T. Packiam, Craig Labbate, Scott Eggener, Randy F. Sweis, Anthony L. Zietman, Jeanny B. Aragon‐Ching and Norm D. Smith and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Urology.

In The Last Decade

Ryan P. Werntz

21 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan P. Werntz United States 10 280 122 85 83 79 23 389
Nico C. Grossmann Switzerland 15 295 1.1× 195 1.6× 42 0.5× 158 1.9× 113 1.4× 58 487
Khaled Hafez United States 12 459 1.6× 196 1.6× 137 1.6× 142 1.7× 181 2.3× 32 655
Ahmet Murat Aydın United States 13 264 0.9× 104 0.9× 63 0.7× 91 1.1× 44 0.6× 50 417
Iwona Skoneczna Poland 10 449 1.6× 147 1.2× 80 0.9× 192 2.3× 58 0.7× 22 589
Ali Hajiran United States 11 212 0.8× 99 0.8× 42 0.5× 55 0.7× 61 0.8× 41 308
Rauf Taner Di̇vri̇k Türkiye 11 538 1.9× 150 1.2× 54 0.6× 56 0.7× 270 3.4× 23 662
Rita Righetti Italy 7 107 0.4× 207 1.7× 136 1.6× 48 0.6× 39 0.5× 11 295
Brian Shinder United States 12 111 0.4× 172 1.4× 81 1.0× 101 1.2× 44 0.6× 31 335
Wassim M. Bazzi United States 15 244 0.9× 401 3.3× 227 2.7× 92 1.1× 22 0.3× 36 522
Hirotaka Akita Japan 12 225 0.8× 325 2.7× 151 1.8× 50 0.6× 62 0.8× 34 596

Countries citing papers authored by Ryan P. Werntz

Since Specialization
Citations

This map shows the geographic impact of Ryan P. Werntz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan P. Werntz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan P. Werntz more than expected).

Fields of papers citing papers by Ryan P. Werntz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan P. Werntz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan P. Werntz. The network helps show where Ryan P. Werntz may publish in the future.

Co-authorship network of co-authors of Ryan P. Werntz

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan P. Werntz. A scholar is included among the top collaborators of Ryan P. Werntz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan P. Werntz. Ryan P. Werntz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Packiam, Vignesh T., Craig Labbate, Stephen A. Boorjian, et al.. (2021). The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis. Urologic Oncology Seminars and Original Investigations. 39(7). 436.e1–436.e8. 8 indexed citations
2.
Werntz, Ryan P. & Scott E. Eggener. (2020). Defining risk of micrometastatic disease and tumor recurrence in patients with stage I testicular germ cell tumors. Translational Andrology and Urology. 9(S1). S31–S35. 2 indexed citations
3.
Labbate, Craig, et al.. (2020). National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy. Urologic Oncology Seminars and Original Investigations. 38(8). 687.e13–687.e18. 5 indexed citations
4.
Marguet, Charles G., et al.. (2020). A rare case of pancreatic adenocarcinoma metastasized to the bladder. Urology Case Reports. 33. 101394–101394.
5.
Labbate, Craig, Ken Hatogai, Ryan P. Werntz, et al.. (2019). Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 66–66. 62 indexed citations
6.
Packiam, Vignesh T., Ryan P. Werntz, & Gary D. Steinberg. (2019). Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage. Current Urology Reports. 20(12). 84–84. 34 indexed citations
7.
Labbate, Craig, et al.. (2019). The Impact of Omission of Intraoperative Frozen Section Prior to Orthotopic Neobladder Reconstruction. The Journal of Urology. 202(4). 763–769. 4 indexed citations
8.
Sweis, Randy F., Shay Golan, Nimrod Barashi, et al.. (2019). Association of the commensal urinary microbiome with response to Bacillus Calmette-Guérin (BCG) immunotherapy in nonmuscle invasive bladder cancer.. Journal of Clinical Oncology. 37(7_suppl). 423–423. 18 indexed citations
9.
Werntz, Ryan P., Ryan Kopp, Jeffrey La Rochelle, et al.. (2018). Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source. Urologic Oncology Seminars and Original Investigations. 36(5). 238.e1–238.e5. 26 indexed citations
10.
Labbate, Craig, et al.. (2018). Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later. Urology. 122. 16–18. 1 indexed citations
11.
Fantus, Richard J, et al.. (2018). The impact of surgical duration on complications after transurethral resection of the prostate: an analysis of NSQIP data. Prostate Cancer and Prostatic Diseases. 22(2). 303–308. 22 indexed citations
12.
Werntz, Ryan P., Shane M. Pearce, & Scott E. Eggener. (2018). Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection. Current Opinion in Urology. 28(5). 461–468. 4 indexed citations
13.
Werntz, Ryan P., Zachary L. Smith, Vignesh T. Packiam, Norm D. Smith, & Gary D. Steinberg. (2018). The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy. European Urology Focus. 6(2). 292–297. 20 indexed citations
14.
Werntz, Ryan P., Richard J Fantus, Zachary L. Smith, et al.. (2018). The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma. Urologic Oncology Seminars and Original Investigations. 36(12). 526.e1–526.e6. 9 indexed citations
15.
Werntz, Ryan P., et al.. (2018). Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC). World Journal of Urology. 37(10). 2031–2040. 11 indexed citations
16.
Smith, Zachary L., et al.. (2018). MP48-04 ROBOTIC-ASSISTANCE IS ASSOCIATED WITH IMPROVED PERIOPERATIVE OUTCOMES IN MINIMALLY-INVASIVE RADICAL NEPHRECTOMY. The Journal of Urology. 199(4S). 1 indexed citations
17.
Smith, Zachary L., Ryan P. Werntz, & Scott E. Eggener. (2017). Testicular Cancer. Medical Clinics of North America. 102(2). 251–264. 112 indexed citations
18.
Werntz, Ryan P., et al.. (2017). A Simple Neobladder Using a Porcine Model: The Double Limb U-Pouch. Urology. 114. 198–201. 1 indexed citations
19.
Werntz, Ryan P. & Scott Eggener. (2017). Novel focal therapy treatment options for prostate cancer. Current Opinion in Urology. 28(2). 178–183. 6 indexed citations
20.
Werntz, Ryan P., et al.. (2015). PD44-02 TRENDS IN PSA UTILIZATION BY PRIMARY CARE PHYSICIANS: IMPACT OF THE USPSTF RECOMMENDATION. The Journal of Urology. 193(4S). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nico C. Grossmann Breakdown of academic impact, for papers by Khaled Hafez Breakdown of academic impact, for papers by Ahmet Murat Aydın Breakdown of academic impact, for papers by Iwona Skoneczna Breakdown of academic impact, for papers by Ali Hajiran Breakdown of academic impact, for papers by Rauf Taner Di̇vri̇k Breakdown of academic impact, for papers by Rita Righetti Breakdown of academic impact, for papers by Brian Shinder Breakdown of academic impact, for papers by Wassim M. Bazzi Breakdown of academic impact, for papers by Hirotaka Akita
Rankless by CCL
2026